Preserflo Microshunt – Intraoperative Application Of 0.02% And 0.04% Mitomycin C: A Comparison Of Clinical Outcomes And Complications With A Follow-Up Of Up To 2.5 Years After Surgery.

Published 2023 - 41st Congress of the ESCRS

Reference: PO0856 | Type: Free paper | DOI: 10.82333/x6fq-qm24